Pediatrix Welcomes Two Nationally Renowned Physician Leaders
Dr. James Barry, who will join as Chief Clinical Quality & Transformation Officer, and Dr. Jochen Profit, who will serve as Chief Quality Advisor, bring extraordinary reputations as care quality experts
Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is pleased to announce that James Barry, M.D., MBA, will soon join the organization as Chief Clinical Quality & Transformation Officer. Jochen Profit, M.D., MPH, will join Dr. Barry as Chief Quality Advisor.
"We are thrilled to welcome two nationally renowned physician leaders to Pediatrix and Obstetrix," said Mark Ordan, Chair of the Board and CEO. "Quality care is at the heart of everything that we do as a leading provider of care for women, babies and children. Drs. Barry and Profit's enormous experience and expertise will help us continue to advance both clinical knowledge and practice for the entire field."
As Chief Clinical Quality & Transformation Officer, Dr. Barry will be responsible for shaping the medical direction of the organization and ensuring the highest standards of patient care. This includes overseeing the work of the Pediatrix Center for Research, Education, Quality and Safety (CREQS), which participates in clinical research, education and continuous quality improvement and safety initiatives at the local and national level to improve outcomes, enhance the patient experience, improve provider satisfaction and reduce health care costs.
"At a time when medical knowledge continues to grow exponentially and technology is reshaping care, Dr. Barry's proven track record as a strategist and innovator will be an incredible asset to our organization and our patients as we move forward," said Ordan.
A neonatologist recognized for his contributions in neonatal critical care, artificial intelligence in medicine, patient safety and health care leadership, Dr. Barry's work has focused on delivering measurable, durable improvement in complex health care systems. He has co-founded two national organizations: NeoMINDAI, a learning collaborative for neonatologists, data scientists and clinical informaticists interested in studying and evaluating the application of artificial intelligence in neonatal critical care and pediatric medicine, and the Clinical Leader's Group of the American Academy of Pediatrics, which is a training, education and collaboration resource for medical and quality directors of neonatal intensive care units (NICUs) in the United States. Dr. Barry joins Pediatrix from the University of Colorado Health System, where he was the long-standing Medical Director of a level III NICU and chair of newborn governance across 14 hospitals, as well as a professor of pediatrics-neonatology at the University of Colorado Anschutz School of Medicine.
"I am honored to be joining Pediatrix," said Dr. Barry. "While our organization is built on a foundation of incredible clinical excellence and unmatched scale, I believe our true strength lies in our collective intelligence. By combining our clinical heart and genuine curiosity with transformative strategy, we will ensure that evidence-based approaches are more accessible and effective across all our clinical sites."
Dr. Profit is a noted health care researcher with more than 20 years of experience in pediatrics and neonatal-perinatal medicine. As Chief Quality Advisor, he will provide expert medical guidance to the company's affiliated clinical leaders and CREQS. His research has primarily focused on the optimization of care delivery to pregnant people and sick newborns and included health system design, care culture and provider well-being, health equity and family-centered care. Dr. Profit serves as Chair and Co-Principal Investigator at the California Perinatal Quality Care Collaborative, Co-Chair and Co-Principal Investigator at the California Maternal Quality Care Collaborative and is the Wendy J. Tomlin-Hess Endowed Professor of Pediatrics at Stanford Medicine. He is a board member of the California Association of Neonatologists and has served in a variety of roles for the National Institutes of Health, the National Academies for Science, Engineering and Medicine, the Vermont Oxford Network and the American Academy of Pediatrics.
"Dr. Profit is widely recognized as among the foremost thought leaders in our field, and we are excited that he is bringing his talents to Pediatrix, where his unyielding focus on improving quality and patient safety will have a national impact," said Ordan.
About Pediatrix Medical Group
Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Specialties include obstetrics, maternal-fetal medicine and neonatology complemented by multiple pediatric subspecialties. The group's high-quality, evidence-based care is bolstered by significant investments in research, education, quality-improvement and safety initiatives. The physician-led company was founded in 1979 as a single neonatology practice and today provides its highly specialized and often critical care services through approximately 4,300 affiliated physicians and other clinicians. To learn more about Pediatrix, visit www.pediatrix.com or follow us on Facebook, Instagram, LinkedIn and the Pediatrix blog. Investment information can be found at www.pediatrix.com/investors.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260324172077/en/
For media inquiries or more information, please contact Pediatrix Communications at [email protected].